Related Experiment Videos
[Prenatal diagnosis of cystic fibrosis with recombinant DNA methods]
1Institut für Humangenetik, Universität Göttingen.
Insights
Cystic fibrosis (CF) is a common genetic disorder affecting 1 in 3000 newborns. Molecular genetic testing allows for accurate prenatal diagnosis of CF, aiding families in reproductive decisions.
Area of Science:
- Medical Genetics
- Genetic Disorders
- Molecular Biology
Context:
- Cystic fibrosis (CF) is a prevalent genetic disorder affecting approximately 1 in 3000 newborns.
- Despite advancements in therapy, individuals with CF experience significantly reduced life expectancy.
- The precise molecular underpinnings of CF remain incompletely understood.
Purpose:
- To review the fundamental principles of cystic fibrosis genetics.
- To outline the diagnostic methodologies for CF, including molecular genetic approaches.
- To provide guidance on prenatal diagnosis for families with a history of CF.
Summary:
- Molecular genetic testing offers highly accurate prenatal detection of cystic fibrosis (CF).
- This review details the genetic basis and diagnostic strategies for CF.
- Practical guidance is provided for risk assessment and performing prenatal diagnosis in affected families.
Impact:
- Enables informed reproductive choices for families at risk of cystic fibrosis.
- Facilitates early identification of CF, potentially improving management strategies.
- Highlights the importance of molecular genetic methods in diagnosing inherited diseases.
Abstract:
Cystic fibrosis is one of the commonest genetic disorders with about 1 in 3000 newborns being affected. The molecular etiology of the disease is still not known. In spite of improved therapy the life expectancy is markedly reduced. Many parents of a child affected by CF request a prenatal diagnosis, when a further child is expected. By using molecular genetic methods the prenatal detection of CF is possible now with great accuracy in most families. This review describes the principles of the genetics and the diagnosis of the disease. Case reports illustrate risk figure ascertainment. Preconditions for performing the diagnosis in individual cases are outlined, and a guide to the practical approach is given.